Meetings and Courses

Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication. This list is provided as a service to readers; inclusion does not imply endorsement by the Hepatobiliary & Pancreatic Diseases International.

Section editor

Shui-Ying Lei

Email: hbpdint@126.com

September, 2017

Gastroenterology & hepatology board review 2017

September 14-17, 2017; Chicago, United States

The Mayo Clinic gastroenterology and hepatology board review is designed for candidates preparing for certif i cation and maintenance of certif i cation (MOC) examinations in gastroenterology and hepatology. The gastroenterology and hepatology board review will include relevant topics such as pathology, endoscopy, radiology and nutrition. Target audiences include GI fellows, GI nurse assistants, gastroenterologists, persons preparing for GI board exams and recertif i cation, gastroenterologists needing MOC, GI nurse practitioners, physician assistants and physician extenders. Upon conclusion of this program, participants should be able to： 1) Identify esophageal, gastric, small bowel and colon diseases and other disorders of the GI tract and liver; 2) Articulate diagnostic therapeutic approaches to management of patients diagnosed with digestive disorders; 3) Discuss relevant areas of pathology, endoscopy, radiology and nutrition. For more information, please contact：Tel： 1-800-323-2688; Email： cme@mayo.edu; Website：https：//ce.mayo.edu/gastroenterology/content/gastroenterology-hepatology-board-review-2017.

3rd annual update in gastroenterology and hepatology

September 23, 2017; Phoenix, United States

This course will provide the latest, state-of-the-art information on the diagnosis and management of common disorders such as esophageal strictures, complications of bariatric surgery, functional GI disorders, colon cancer screening, IBD, fatty liver, hepatitis B and C, dermatologic manifestation of various GI conditions. In addition, advances in liver transplantation and endoscopic innovations will be presented. The intended audience includes gastroenterologists, hepatologists, primary care physicians, nurses and advanced healthcare practitioners. Course format will offer didactic lectures, panel discussions and interactive Q&A. For more information, please contact： Email： mca.cme@mayo.edu.

EASL-AASLD joint meeting on alcoholic liver disease and alcoholic hepatitis

September 30-October 1, 2017; London, United Kingdom

This joint meeting will bring together the major stakeholders in the area of alcoholic liver disease to combine expertize of scientists, clinicians, regulatory agencies and pharmaceutical interest to def i ne new directions, discuss clinical trial design and evaluate clinical endpoints in alcoholic liver disease and alcoholic hepatitis. During the EASL-AASLD joint meeting on “Def i nition, therapeutic advances and clinical endpoints in alcoholic liver disease and alcoholic hepatitis” topics on public health, diagnostic def i nitions, therapeutic advances and clinical endpoints in alcohol related liver disease and alcoholic hepatitis will be discussed. Attendees include clinicians, researchers, industry, biotech companies, patient advocacy groups. For any further information, please visit： sit http：//www.easl.eu/discover/events/detail/2017/definitiontherapeutic-advances-and-clinical-endpoints-in-alcoholicliver-disease-and-alcoholic-hepatitis.

October

Introduction to oncology and cancer treatment

October 4-5, 2017; London, United Kingdom

Sessions include： 1) Cancer： Terminology and classif i cation; 2) Clinical trial issues in oncology; 3) Introduction to anti-cancer drugs and side-effects; 4) New developments in cancer therapy; 5) Introduction to the major tumour types： breast, lung, colorectal, ovarian, skin cancer, upper gastrointestinal (GI) and prostate cancer; 6) Clinical trial issues in oncology. Courses will benef i t medical and non-medical staff within the pharmaceutical, biotechnology, medical device and associated healthcare industries. This course is suitable for clinical research, medical information, regulatory affairs, biometrics and strategic marketing personnel. For more information, please contact： Email： courses@healthcareed.com.

7th interAmerican oncology conference “current status and future of anti-cancer targeted therapies”

October 5-6, 2017; Buenos Aires, Argentina

The VII conference of IAOC “current status and future of anti-cancer targeted therapies” will be held in Buenos Aires, Argentina in October 5-6, 2017. The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most commontumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development. This meeting is the primary opportunity for practicing oncologists, hematologists, urologists, basic clinical and translational investigators, scientists and cancer related health care workers to participate in a conference focusing on novel targeted therapies and other treatment advances which are changing the face of cancer care. The meeting does not charge a registration fee and the presentations are translated into Spanish in real time for the attendees. For more information, please contact： Email： secretariat@oncologyconferences.com.ar; Website： http：//www.oncologyconferences.com.ar/.

5th international oncology conference 2017

October 12-13, 2017; Abu Dhabi, United Arab Emirates

The “5th International Oncology Conference” is to be held on October 12-13, 2017 at Jumeirah Etihad Towers Hotel in Abu Dhabi, UAE. Cancer as a disease is on the top of the health agenda of all the countries and Collective efforts, collaborations and joint forces worldwide are leading to huge developments in the areas of initial diagnosis and prevention. The program will emphasize on the theme “Navigating cancer care by early detection and prevention” to highlight the importance of screening, early diagnosis and prevention of cancer leading to successful treatment outcomes. The conference will also scope issues and challenges in this critical fi eld in order to raise awareness and consider ways towards better care for cancer patients. The meeting will feature prominent national and international speakers, renowned teaching faculty and thought leading experts from major cancer institutes across the globe to discuss your challenging cases and to encourage exchange of knowledge, experience and best practices to fi ght and prevent cancer, making tangible difference for our patients. For more information, please visit： http：//menaconference.com/ events/5oncology//.

6th international conference on clinical and medical case reports

October 16-18, 2017; San Francisco, United States

ICMCR 2017 cordially welcomes high quality late breaking abstract (case reports and clinical research) submissions in following specialties： internal medicine, surgery and all sub-specialties including cardiovascular diseases, gastrointestinal and hepatic diseases, respiratory disorders, infectious diseases, endocrine and metabolic disorders, hematology, musculoskeletal disorders, allergy-Immunology, oncology, rare/orphan diseases, renal diseases, rheumatology, genetic disorders, geriatrics, and other. For more information, please contact： Email：mail casereportsamerica@conferenceseries.net; website： http：// casereports.conferenceseries.com/.

United European gastroenterology (UEG) week Barcelona 2017

October 28-November 1, 2017; Barcelona, Spain

The UEG Week Postgraduate Teaching comprises two days of world-class Continuing Medical Education for gastroenterologists in training and in practice. It also offers established GI physicians and general practitioners profound updates of latest developments in GI and hepatology topics. The focus for the 25th UEG Week 2017 in Barcelona will be to advance science and link people in the global GI community. UEG’s mission is to continuously improve standards of care in gastroenterology, and promote ever greater understanding of digestive and liver disease - among the public and medical experts alike. For more information, please visit： https：//www. ueg.eu/week/.

November

EMBL conference: cancer genomics

November 5-8, 2017; Heidelberg, Germany

This conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer mouse models and the translation and clinical impact of scientif i c results obtained. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts. For more information, please visit： https：//www. embl.de/training/events/2017/CAN17-01/index.html.

10.1016/S1499-3872(17)60048-1)